title: Benazepril, an angiotensin converting enzyme inhibitor: drug interaction with salbutamol and bronchial response to histamine in normal subjects.
abstract: OBJECTIVE
  To investigate the effect of the angiotensin converting enzyme inhibitor, benazepril, on pulmonary function.
  
  
  METHODS
  We investigated the influence of benazepril, on lung function and the interaction with inhaled salbutamol (0.1 to 6.6 mg) and histamine (0.03 to 30.69 g l-1) in normal subjects. Benazepril 20 mg, salbutamol 8 mg, propranolol 160 mg, and placebo were given orally once daily over 10 days.
  
  
  RESULTS
  On day 8, there was no difference in the area under the salbutamol dose-response curves between benazepril, placebo and oral salbutamol (P > 0.05), propranolol shifted the curves to the right (P < 0.05). On day 10, histamine challenge resulted in following PD35sGaw values (geometric mean and 95% CI): with placebo 1.02 (0.95-1.09) g l-1, benazepril 1.04 (0.99-1.08), salbutamol 1.19 (1.13-1.25), propranolol 0.57 (0.50-0.65).
  
  
  CONCLUSIONS
  Benazepril had no influence on baseline lung function, caused no interaction with inhaled salbutamol and the bronchial response to histamine was similar to placebo. However, our findings in normal subjects cannot be extrapolated automatically to asthmatics.
authors.affiliation: Department of Clinical Pharmacology, University of Vienna Medical School, Austria.
authors.forename: K G
authors.initials: KG
authors.lastname: Bauer
authors.forename: P
authors.initials: P
authors.lastname: Brunel
authors.forename: G
authors.initials: G
authors.lastname: Nell
authors.forename: G
authors.initials: G
authors.lastname: Quinn
authors.forename: G A
authors.initials: GA
authors.lastname: Kaik
mesh_terms: D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001552:Benzazepines / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006439:Hemodynamics / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D011188:Potassium / Q000097:blood
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D001786:Blood Glucose; D006632:Histamine; D000420:Albuterol; D011188:Potassium; C044946:benazepril